Gilteritinib Indian version

gilteritinibis an anti-tumor drug, applicable to patients with FMS-like tyrosine kinase3 (FLT3)The treatment of patients with relapsed or refractory acute myeloid leukemia(AML)mutations.

Giritinib is already on the market in China, but it is not currently covered by medical insurance and the cost is high. Patients may also consider generic drugs that are officially on the market. They are currently produced by Nanta Pharmaceuticals in Laos and have government approval. There are no formal pharmaceutical factories in India. The domestically imported pharmacy price40mg*21tablets*2board258000< span> yuan, the retail price of Laos pharmaceutical factory is about 40mg90 tablets4000 yuan. Patients can choose the version according to their own financial situation.

The most common adverse reactions of giritinib (≥20%) are increased aminotransferases, myalgia, joint pain, fatigue, malaise, fever, mucositis, edema, rash, non-infectious diarrhea, dyspnea, nausea, cough, constipation, eye disease, headache, dizziness, hypotension, vomiting and renal impairment. Patients receiving geritinib have developed symptoms of differentiation syndrome, which may be fatal or life-threatening if left untreated. Symptoms may include fever, dyspnea, hypoxia, pulmonary infiltrates, pleural or pericardial effusion, rapid weight gain or peripheral edema, hypotension, or renal insufficiency. If differentiation syndrome is suspected, initiate corticosteroid therapy and hemodynamic monitoring until symptoms resolve. There are many versions of generic drugs, priced at around three to four thousand per box. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.

xa0